Introducing UltraGuideCTR™, formerly known as the SX-One MicroKnife. UltraGuideCTR is the same device with the same intended use, indications for use and clinical data regarding the safety and effectiveness of the device.
Carpal Tunnel Release (CTR) with ultrasound guidance has been performed for more than 24 years. The technique was first documented in a medical journal in 1997.
Introducing UltraGuideCTR™, formerly known as the SX-One MicroKnife. UltraGuideCTR is the same device with the same intended use, indications for use and clinical data regarding the safety and effectiveness of the device.
More than 15,000 procedures have been performed in the United States using UltraGuideCTR and real-time ultrasound guidance.
There are 31 peer reviewed publications regarding CTR using ultrasound guidance, including 9 publications specific to CTR with UltraGuideCTR and real-time ultrasound guidance. These studies have shown:
Additionally, the APEX (Assessment of the Patient EXperience) patient database tracks patient outcomes for CTR using ultrasound guidance with the UltraGuideCTR:
To date, 24 physicians have enrolled more than 400 patients into the database.
The majority of CTR procedures using ultrasound guidance are performed in a procedure room or office setting.
CTR with the UltraGuideCTR and ultrasound guidance is typically performed using local anesthesia.
The small wrist incision is typically closed without stitches.
Most patients only require Tylenol or Ibuprofen for pain management.
When clinically indicated, a patient can have CTR with the UltraGuideCTR and ultrasound guidance performed on both wrists on the same day. There are several published manuscripts that include outcomes data on patients who had simultaneous bilateral releases.
Postoperative therapy is typically not required.
Many patients can tolerate immediate motion of their hand for rapid recovery.
References: